Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorPublished on 13/05/2014
Polymer Therapeutics include biologically active polymeric drugs and polymeric sequestrants, polymer-protein and polymer-drug conjugates, block copolymer micelles, and the supramolecular assemblies that form multi-component polyplexes designed to promote cytosolic delivery of genes, siRNAs and proteins. These constructs are amongst the most successful first generation "Nanomedicines" with a growing number of products approved by Regulatory Authorities for routine clinical use, and many others progressing through clinical trials as single agents or as components of combination therapy regimes. The first follow-on ("generic") polymer therapeutics are emerging.
Unlike other Drug Delivery Symposia that have a broader remit, this unique conference series was specifically established to provide a forum for interdisciplinary exchange of state-of-the-art techniques and advances in knowledge relating to the design, clinical development and commercialisation of Polymer Therapeutics.
The key topics discussed during the 10th International Symposium on Polymer Therapeutics are:
Polymer - synthesis, safety, development to clinical use
Linkers - design, mechanisms for triggered degradation
Opportunities for Targeting
Proposed Clinical Use - models for determining in vitro and in vivo PK, PD, safety
Current Clinical Status
Industrial Development and Regulation